Can prostaglandins be used in an asthmatic patient?
Prostaglandins are frequently used for cervical ripening, labor induction, and postpartum hemorrhage. Their safety profile varies depending on prostaglandin subtype.
SAFE in asthma
- Prostaglandin E1 (PGE₁): Misoprostol
- Limited data suggests Prostaglandin E2 (PGE₂) is also safe and may be used when indicated: Dinoprostone
Both PGE₁ and PGE₂ have bronchodilatory properties and are considered safe for use in pregnant patients with asthma when clinically indicated.
Large prospective experience (Towers et al.) demonstrates no asthma exacerbations among 189 asthmatic patients receiving PGE₂ for induction.
NOT SAFE in asthma
- Prostaglandin F2α (PGF₂α): Carboprost (Hemabate®)
PGF₂α is a potent bronchoconstrictor and may precipitate severe bronchospasm. ACOG, SMFM, obstetric anesthesia organizations, and GINA guidelines advise avoiding carboprost in asthma unless no alternatives exist.
Clinical Summary
- PGE₁ (misoprostol) — safe for induction or postpartum use
- PGE₂ (dinoprostone) — safe for induction and cervical ripening
- PGF₂α (carboprost) — avoid in asthma
All patients with asthma should be monitored closely with any uterotonic agent, but asthma itself is not a contraindication to misoprostol or dinoprostone.
References
1. Dombrowski MP. Asthma and pregnancy. Obstet Gynecol. 2006.
2. Towers CV, et al. Use of prostaglandin E2 in pregnant patients with asthma. Am J Obstet Gynecol. 2004.
3. GINA (Global Initiative for Asthma) Guidelines. Updated 2023.
4. ACOG Practice Bulletin: Asthma in Pregnancy. Updated 2020–2024.
5. Cytotec® (misoprostol) and Cervidil® (dinoprostone) package inserts. Updated 2023.